Postoperative Analgesic Efficacy of Transversus Abdominis Plane in Laparoscopic Abdominal Surgeries
Not Applicable
Recruiting
- Conditions
- SurgeryLaparoscopic Abdominal Surgeries
- Registration Number
- PACTR201803003108330
- Lead Sponsor
- Rehab Said ElKalla
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
ASA I ¿ III of both sex, between 18 and 60 years undergoing laparoscopic abdominal surgeries
Exclusion Criteria
Open surgeries.
- If the surgery proceeded to laparotomy.
- BMI ¿ 35 Kg/m.
- Known allergy or hypersensitivity against levobupivacaine, other amino-amide local anesthetics, or dexmedetomidine.
- Coagulopathy; septicemia.
- Abnormalities in ECG that are considered clinically relevant like AV block or bradycardia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of Levobupivacaine with Dexmedetomidine in TAP blocks for laparoscopic abdominal surgeries?
How does the efficacy of Ultrasound Guided Transversus Abdominis Plane block compare to standard-of-care analgesia in postoperative laparoscopic abdominal surgery patients?
Are there specific biomarkers that can predict patient response to Levobupivacaine with Dexmedetomidine in TAP blocks for laparoscopic abdominal surgeries?
What are the potential adverse events associated with Levobupivacaine and Dexmedetomidine combination in TAP blocks, and how can they be managed?
What are the current trends in combination analgesic approaches for laparoscopic abdominal surgeries, and how does this trial contribute to the field?